| 000 | 02527 a2200697 4500 | ||
|---|---|---|---|
| 005 | 20250517181824.0 | ||
| 264 | 0 | _c20180611 | |
| 008 | 201806s 0 0 eng d | ||
| 022 | _a2047-9980 | ||
| 024 | 7 |
_a10.1161/JAHA.117.006635 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStuhlmiller, Timothy J | |
| 245 | 0 | 0 |
_aKinome and Transcriptome Profiling Reveal Broad and Distinct Activities of Erlotinib, Sunitinib, and Sorafenib in the Mouse Heart and Suggest Cardiotoxicity From Combined Signal Transducer and Activator of Transcription and Epidermal Growth Factor Receptor Inhibition. _h[electronic resource] |
| 260 |
_bJournal of the American Heart Association _cOct 2017 |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtoxicity |
| 650 | 0 | 4 | _aCardiotoxicity |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aEchocardiography |
| 650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aErlotinib Hydrochloride _xtoxicity |
| 650 | 0 | 4 |
_aFatty Acids _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Expression Profiling |
| 650 | 0 | 4 |
_aHeart _xdiagnostic imaging |
| 650 | 0 | 4 |
_aHeart Diseases _xchemically induced |
| 650 | 0 | 4 |
_aIndoles _xtoxicity |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 |
_aMyocardial Contraction _xdrug effects |
| 650 | 0 | 4 |
_aMyocardium _xenzymology |
| 650 | 0 | 4 |
_aMyocytes, Cardiac _xdrug effects |
| 650 | 0 | 4 |
_aNiacinamide _xanalogs & derivatives |
| 650 | 0 | 4 | _aOxidation-Reduction |
| 650 | 0 | 4 |
_aPhenylurea Compounds _xtoxicity |
| 650 | 0 | 4 | _aProtein Interaction Maps |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xtoxicity |
| 650 | 0 | 4 | _aProteomics |
| 650 | 0 | 4 |
_aPyrroles _xtoxicity |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aSTAT3 Transcription Factor _xantagonists & inhibitors |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 | _aSorafenib |
| 650 | 0 | 4 | _aSunitinib |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aZawistowski, Jon S | |
| 700 | 1 | _aChen, Xin | |
| 700 | 1 | _aSciaky, Noah | |
| 700 | 1 | _aAngus, Steven P | |
| 700 | 1 | _aHicks, Sean T | |
| 700 | 1 | _aParry, Traci L | |
| 700 | 1 | _aHuang, Wei | |
| 700 | 1 | _aBeak, Ju Youn | |
| 700 | 1 | _aWillis, Monte S | |
| 700 | 1 | _aJohnson, Gary L | |
| 700 | 1 | _aJensen, Brian C | |
| 773 | 0 |
_tJournal of the American Heart Association _gvol. 6 _gno. 10 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/JAHA.117.006635 _zAvailable from publisher's website |
| 999 |
_c27703617 _d27703617 |
||